APP and Alzheimer disease: Furthermore, miR-149-5p-mediated KAT8 suppression reduced global H4K16ac levels in 293/APPsw cells, leading to decreased soluble amyloid beta precursor protein (APP) beta peptide production and potentially attenuating Alzheimer’s disease progression [144].